ICIn Hee Choi

In Hee Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


In Hee Choi has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Self‐efficacy of genetic counselors and genetic counseling students using the Korean genetic counseling self‐efficacy scale

    by In Hee Choi, Sunhee Tak, Su Min Ji, Seo Yeon Yang

    This study applied the Korean version of the Genetic Counseling Self‐Efficacy Scale (K‐GCSES) to compare self‐efficacy between certified genetic counselors and master's‐level genetic counseling students in South Korea and examine associations with clinical, educational, and research experience. Data were obtained from a cross‐sectional online survey conducted between March and May 2024 among 33 certified genetic counselors and 18 genetic counseling students ( n = 51). Self‐efficacy was measured using the 33‐item K‐GCSES, and group differences and experience‐related associations were analyzed using Welch's t ‐tests, Holm adjustment, Hedges' g , and Jonckheere–Terpstra trend tests. Certified genetic counselors (total K‐GCSES score: mean [ M ] = 7.53, standard deviation [SD] = 1.67) reported significantly higher overall self‐efficacy than students ( M = 5.75, SD = 1.47; t (39.0) = 3.94, p < 0.001, Hedges' g = 1.09). Medium to large effect sizes were observed across all three K‐GCSES factors, including counseling competence and psychosocial skills, genetic testing, and information gathering ( g = 0.95–1.35), with the largest group difference observed for the genetic testing factor ( g = 1.35, p < 0.001). Within the genetic counselor group, years of practice ( p < 0.001), number of counseling cases ( p = 0.006), and participation in genetic counseling–related academic activities during the past 2 years ( p = 0.003) were positively associated with self‐efficacy, and counselors with research experience had higher total scores than those without ( p = 0.018). Among students, self‐efficacy varied according to supervised clinical practicum case volume. These findings indicate that self‐efficacy is more closely associated with accumulated clinical practice than solely theoretical coursework, providing empirical evidence to inform genetic counseling education and workforce development strategies in South Korea.

  • Open Access

    Caregiver quality of life and burden in rare genetic diseases in South Korea

    by Sunyoung Rn Choi, Ja Hye Kim, Gu-Hwan Kim, Beom Hee Lee, In Hee Rn Choi

    Caregivers of individuals with rare genetic diseases experience substantial and persistent challenges that negatively affect their quality of life (QoL) and increase their burden. This study explored factors associated with caregiver QoL and burden in South Korea, focusing on patient characteristics, treatment availability, and genetic counseling experience. A cross-sectional survey was conducted with 159 caregivers of patients with rare genetic diseases at a tertiary general hospital. Caregiver QoL and burden were measured using the Caregiver QoL Scale and the Korean version of the Burden Assessment Scale. Demographic and clinical characteristics were also collected. Statistical analyses were performed using R software. Group differences were evaluated using Welch t tests, Wilcoxon rank-sum tests, and one-way analysis of variance with post hoc tests. Correlation analyses examined associations between QoL and caregiver burden. Caregiver QoL was significantly higher among those caring for minors, whereas caregiver burden was significantly higher among those caring for patients with registered disabilities. Treatment availability was associated with higher caregiver QoL and lower burden. Disease category also influenced outcomes: caregivers of patients with progressive conditions and localized impairments reported significantly lower QoL than those caring for patients with chronic conditions with effective treatment or symptomatic care or stable conditions with disabilities. Conversely, caregivers of patients with fatal diseases lacking effective treatment reported significantly higher burden than those caring for patients with chronic conditions with effective treatment. Caregiver QoL and burden were strongly and negatively correlated. Most caregivers (68.6%) had no prior genetic counseling experience, although those with counseling experience reported higher family openness scores, a QoL subdomain. Caregiver QoL and burden are closely linked to patient characteristics, treatment availability, and contextual caregiving demands. Expanding access to effective treatments, improving service accessibility, and integrating genetic counseling into caregiver support systems may improve the well-being of families affected by rare genetic diseases.

  • Open Access

    Evaluation of Team-Based Genetic Counseling Services in Korea

    by In Hee Choi, Su Min Ji, Seo Yeon Yang, Gu-Hwan Kim, Jinhee Lee, Sunyoung Choi, Beom Hee Lee

    Choi IH, et al. J Korean Med Sci. 2026 Apr;41(16):e125. https://doi.org/10.3346/jkms.2026.41.e125

  • Open Access

    Beyond CHD7 gene: unveiling genetic diversity in clinically suspected CHARGE syndrome

    by Dohyung Kim, Ji-Hee Yoon, Hyunwoo Bae, Soojin Hwang, Go Hun Seo, June-Young Koh, Young Seok Ju, Hyo-Sang Do, Soyoung Kim, In Hee Choi, et al.

    The Verloes or Hale diagnostic criteria have been applied for diagnosing CHARGE syndrome in suspected patients. This study was conducted to evaluate the diagnostic rate of CHD7 according to these diagnostic criteria in suspected patients and also to investigate other genetic defects in CHD7-negative patients. The clinical findings and the results of genetic testing of CHD7, chromosome microarray, exome sequencing, or genome sequencing of 59 subjects were reviewed. CHD7 pathogenic variants were identified in 78% of 46 subjects who met either the Verloes or Hale diagnostic criteria and in 87% of 38 subjects who met both criteria, whereas no CHD7 variant was detected in 13 subjects who met neither criterion. Among 23 patients without the CHD7 variant, six genetic diseases were identified in 7 patients, including Wolf–Hirschhorn syndrome, 1q21 deletion syndrome, 19q13 microdeletion, and pathogenic variants in PLCB4, TRRAP, and OTX2. Based on these comprehensive analyses, the overall diagnostic rate was 73% for seven different genetic diseases. This study emphasizes the importance of comprehensive clinical and genetic evaluation in patients with clinically suspected CHARGE syndrome, recognizing the overlapping phenotypes in other rare genetic disorders.


  • Open Access

    A qualitative study on the field experience of genetic counseling in Korea

    by In Hee Choi, JeongYun Park, Haeng‐Mi Son

    In Korea, genetic counseling services began with the opening of genetic clinics in the early 1990s; in recent years, demand for these services has increased. However, genetic counseling is not an officially recognized healthcare service under the Korean national health insurance system; further, its certification is not recognized as a medical qualification. To clarify the role and significance of genetic counselors, this study examined their field experiences. To this end, we conducted focus group interviews with 11 certified genetic counselors, six advanced practice nurses, and four regular nurses. The interviews were transcribed verbatim and examined using thematic analysis. We found that even though Korea did not recognize their roles, the participants met their responsibilities and primary duties. In addition, they faced challenges during counseling due to a lack of formal education in genetics and genomics. Moreover, they encountered dilemmas related to the legal and ethical aspects of decision support for family testing or prenatal diagnosis due to the complexity of rare genetic disorders. However, they attempted to acquire the specialized knowledge needed to support patients with rare genetic disorders and their families, gradually developing practical experience and specialized knowledge. Therefore, it is necessary to develop manuals, establish systems, and improve working environments to provide high‐quality and specialized genetic counseling. Additionally, there is a need for national support, such as establishing set wages for genetic counselors, developing a national qualification certification system, and securing dedicated personnel.


  • Open Access

    Cross‐cultural validation of the genetic counseling outcome scale in Korea

    by Sojin Yang, Yoon Jung Chang, Kyung Ok Kim, Beom Hee Lee, Sun‐Young Kong, Marion McAllister, In Hee Choi

    The Genetic Counseling Outcome Scale (GCOS‐24) was developed to measure patient‐reported outcomes to evaluate the effectiveness of genetic counseling and testing services. In the current study, the Korean version of GCOS (K‐GCOS) was developed to reflect the sociocultural characteristics of Korea, and its clinical applicability was assessed. Overall, 231 Koreans, including patients with genetic diseases and their family members, participated and completed the K‐GCOS, Hospital Anxiety and Depression Scale (HADS), Multidimensional Health Locus of Control (MHLC) scale, and Satisfaction with Life Scale (SWLS). Validity was examined by assessing the correlations between K‐GCOS scores and other relevant scale scores. Reliability was confirmed using Cronbach's alpha and test–retest scores, measured over 2 weeks. We performed exploratory factor analysis of the five structures of GCOS‐24. For K‐GCOS, four‐factor structures were identified: “cognitive–behavioral control,” “uncertainty about control,” “hope,” and “emotional regulation.” Four original GCOS‐24 items were removed because of low factor loadings and small inter‐item correlations. K‐GCOS‐20 scores were positively correlated with SWLS (r = 0.456) and MHLC‐internal (r = 0.213) scores but negatively correlated with HADS (anxiety r = −0.428, depression r = −0.469) and MHLC‐internal (r = −0.278) scores. These findings demonstrate that K‐GCOS‐20 is a reliable and valid tool for evaluating genetic counseling services in Korea.


  • Open Access

    Development and verification of the Korean version of the genetic counseling self‐efficacy scale

    by Sunhee Tak, Beom Hee Lee, In Hee Choi

    A self‐reported Genetic Counseling Self‐Efficacy Scale (GCSES) was developed in English to measure genetic counselors' self‐efficacy, a factor known to affect their job performance. This study verified the reliability and validity of the GCSES for use in Korea. The scale was translated and back‐translated into Korean for cultural fit verification. Expert analysis was performed to ensure content validity. For construct validity, a confirmatory factor analysis of the six‐factor structures of the GCSES and an exploratory factor analysis (EFA) of the K‐GCSES were conducted. To confirm the convergent validity and discriminant validity of the items, a multitrait/multi‐item matrix analysis of the relationship between items and subscales was conducted. The reliability was evaluated by examining internal consistency and test–retest reliability. A total of 62 participants were recruited from certified genetic counselors associated with the Korean Society of Medical Genetics and Genomics and from four graduate schools offering genetic counseling programs. Confirmatory factor analysis showed an inadequate fit to the original GCSES structure. Through EFA, three‐factor structures were identified: “counseling competence and psychosocial skills,” “genetic testing,” and “information gathering.” Of the original 38 GCSES items, five were removed due to low factor loadings and small inter‐item correlations. The item convergent validity and discriminant validity of the Korean version of the GCSES were established, and the correlation between the subfactors showed statistical significance (0.711–0.983). Cronbach's alpha was 0.985, and the intraclass correlation coefficient ranged from 0.882 to 0.897, securing reliability. The K‐GCSES has a three‐factor structure with acceptable reliability and sufficient validity. Differences in the factor structure between the K‐GCSES and GCSES may be due to cultural factors. K‐GCSES can be used as a tool to evaluate the competence of genetic counselors and genetic counseling students in Korea and to improve the quality of professionalism and education.


  • Open Access

    Survey of patient satisfaction with genetic counseling services in Korea

    by In Hee Choi, Yun Kyung Kim, Seo Yeon Yang, Vit‐Na Choi, Su Min Ji, Jun Young Kim, Beom Hee Lee

    Since the 1990s, genetic clinics have been established in South Korea, enabling the provision of clinical genetics services. However, genetic counseling services are not widely used in the medical system. In contrast, recently, the demand for genetic counseling has increased due to the rapid development of genomic medicine. Therefore, it is important for medical geneticists and genetic counselors to collaboratively provide genetic counseling services. This study aimed to evaluate the perception and satisfaction of patients with rare genetic diseases and their families regarding genetic counseling services provided by a genetics team at the medical genetics center of a tertiary general hospital for rare genetic diseases. From April to November 2021, a survey was conducted with 203 individuals, including 111 and 92 individuals in the patient and family groups, respectively. Overall, 164 individuals (80.8%) responded that they were aware of genetic counseling services, and 135 individuals (66.5%) responded that they were aware of the role of genetic counselors. Patients and their families wanted to receive information about the following from genetic counseling: clinical manifestation and prognosis of the diagnosed disease (78.8%), treatment and management of the disease (60.6%), risk of recurrence within the family (55.7%), treatment options and alternatives for family and prenatal testing, and various support services. The score of satisfaction with genetic counseling services provided by the genetics team was 8.19 ± 1.68 out of 10. Patients with rare genetic diseases and their families were satisfied with genetic counseling services regarding their diseases, test results, and treatment options. Moreover, the patients could receive psychosocial support and referrals to other medical service providers and support services. As a genetic team approach, collaboration between medical geneticists and certified genetic counselors would be useful in providing information and in diagnosing, treating, and managing patients.


  • Open Access

    Evaluation of users’ level of satisfaction for an artificial intelligence-based diagnostic program in pediatric rare genetic diseases

    by In Hee Rn Choi, Go Hun Seo, JeongYun RN Park, Yoon-Myung Kim, Chong Kun Cheon, Arum Oh, Jung Hye Byeon, Eungu Kang, Young-Lim Shin, Ji Eun Lee, et al.

    The artificial intelligence (AI)-based genetic diagnostic program has been applied to genome sequencing to facilitate the diagnostic process. The objective of the current study was to evaluate the experience and level of satisfaction of participants using an AI-based diagnostic program for rare pediatric genetic diseases. The patients with neurodevelopmental disorders or hearing impairments, their guardians, and their physicians from 16 tertiary general hospitals were enrolled. The study period was from April 2020 to March 2021. A survey was designed to assess their experience and level of satisfaction. A total of 30 physicians and 243 patients and guardians (199 neurodevelopmental disorders and 44 hearing impairments) completed the survey. DNA samples of the subjects were collected through buccal swabs or blood collection: 211 subjects (86.8%) through buccal swab and 29 subjects (11.9%) through blood collection. Average turnaround time for result receipt was 57.54 ± 32.42 days. For the sampling method, 193 patients and guardians (81.1%) and 28 physicians (93.3%) preferred buccal swab. The level of satisfaction of the 2 groups participating in the AI-based diagnostic program was 8.31 ± 1.71 out of 10 in the patient and guardian group and 8.42 ± 1.23 in the physician group. Clinicians, patients, and guardians are satisfied with the AI-based diagnostic program in general. With an increase in AI-based precision medicine solutions, the evaluation of the user’s satisfaction with appropriate provision will help improve personal health care.


  • Open Access

    De Novo Development of mtDNA Deletion Due to Decreased POLG and SSBP1 Expression in Humans

    by Yeonmi Lee, Taeho Kim, Miju Lee, Seongjun So, Mustafa Zafer Karagozlu, Go Hun Seo, In Hee Choi, Peter C. W. Lee, Chong-Jai Kim, Eunju Kang, et al.

    Defects in the mitochondrial genome (mitochondrial DNA (mtDNA)) are associated with both congenital and acquired disorders in humans. Nuclear-encoded DNA polymerase subunit gamma (POLG) plays an important role in mtDNA replication, and proofreading and mutations in POLG have been linked with increased mtDNA deletions. SSBP1 is also a crucial gene for mtDNA replication. Here, we describe a patient diagnosed with Pearson syndrome with large mtDNA deletions that were not detected in the somatic cells of the mother. Exome sequencing was used to evaluate the nuclear factors associated with the patient and his family, which revealed a paternal POLG mutation (c.868C > T) and a maternal SSBP1 mutation (c.320G > A). The patient showed lower POLG and SSBP1 expression than his healthy brothers and the general population of a similar age. Notably, c.868C in the wild-type allele was highly methylated in the patient compared to the same site in both his healthy brothers. These results suggest that the co- deficient expression of POLG and SSBP1 genes could contribute to the development of mtDNA deletion.